North Star Investment Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $227K | Buy |
1,347
+84
| +7% | +$14.4K | 0.01% | 482 |
|
|
2025
Q4 | $213K | Hold |
1,263
| – | – | 0.01% | 434 |
|
|
2025
Q3 | $182K | Hold |
1,263
| – | – | 0.01% | 443 |
|
|
2025
Q2 | $160K | Sell |
1,263
-225
| -15% | -$27.6K | 0.01% | 452 |
|
|
2025
Q1 | $190K | Hold |
1,488
| – | – | 0.01% | 418 |
|
|
2024
Q4 | $197K | Hold |
1,488
| – | – | 0.01% | 420 |
|
|
2024
Q3 | $217K | Hold |
1,488
| – | – | 0.02% | 407 |
|
|
2024
Q2 | $204K | Hold |
1,488
| – | – | 0.02% | 403 |
|
|
2024
Q1 | $204K | Sell |
1,488
-1,240
| -45% | -$169K | 0.01% | 412 |
|
|
2023
Q4 | $371K | Hold |
2,728
| – | – | 0.03% | 361 |
|
|
2023
Q3 | $334K | Hold |
2,728
| – | – | 0.03% | 370 |
|
|
2023
Q2 | $346K | Hold |
2,728
| – | – | 0.03% | 374 |
|
|
2023
Q1 | $352K | Hold |
2,728
| – | – | 0.03% | 381 |
|
|
2022
Q4 | $358K | Hold |
2,728
| – | – | 0.03% | 367 |
|
|
2022
Q3 | $319K | Hold |
2,728
| – | – | 0.03% | 332 |
|
|
2022
Q2 | $321K | Hold |
2,728
| – | – | 0.03% | 338 |
|
|
2022
Q1 | $355K | Hold |
2,728
| – | – | 0.03% | 331 |
|
|
2021
Q4 | $416K | Buy |
2,728
+565
| +26% | +$87.5K | 0.03% | 326 |
|
|
2021
Q3 | $350K | Hold |
2,163
| – | – | 0.03% | 334 |
|
|
2021
Q2 | $354K | Buy |
2,163
+675
| +45% | +$104K | 0.03% | 328 |
|
|
2021
Q1 | $224K | Hold |
1,488
| – | – | 0.02% | 356 |
|
|
2020
Q4 | $225K | Buy |
1,488
+888
| +148% | +$127K | 0.02% | 343 |
|
|
2020
Q3 | $81K | Hold |
600
| – | – | 0.01% | 439 |
|
|
2020
Q2 | $82K | Hold |
600
| – | – | 0.01% | 419 |
|
|
2020
Q1 | $65K | Hold |
600
| – | – | 0.01% | 444 |
|
|
2019
Q4 | $72K | Hold |
600
| – | – | 0.01% | 492 |
|
|
2019
Q3 | $60K | Buy |
+600
| New | +$62.8K | 0.01% | 517 |
|
|
2019
Q2 | – | Sell |
-600
| Closed | -$67K | – | 631 |
|
|
2019
Q1 | $67K | Sell |
600
-580
| -49% | -$63.6K | 0.01% | 501 |
|
|
2018
Q4 | $114K | Buy |
1,180
+210
| +22% | +$22.3K | 0.01% | 396 |
|
|
2018
Q3 | $118K | Hold |
970
| – | – | 0.01% | 420 |
|
|
2018
Q2 | $107K | Buy |
970
+370
| +62% | +$39.6K | 0.01% | 436 |
|
|
2018
Q1 | $64K | Sell |
600
-750
| -56% | -$83.1K | 0.01% | 510 |
|
|
2017
Q4 | $144K | Buy |
1,350
+750
| +125% | +$80.2K | 0.02% | 388 |
|
|
2017
Q3 | $67K | Hold |
600
| – | – | 0.01% | 495 |
|
|
2017
Q2 | $62K | Sell |
600
-39
| -6% | -$3.84K | 0.01% | 500 |
|
|
2017
Q1 | $62K | Hold |
639
| – | – | 0.01% | 489 |
|
|
2016
Q4 | $57K | Buy |
639
+15
| +2% | +$1.36K | 0.01% | 482 |
|
|
2016
Q3 | $60K | Hold |
624
| – | – | 0.01% | 388 |
|
|
2016
Q2 | $54K | Sell |
624
-150
| -19% | -$13.5K | 0.01% | 400 |
|
|
2016
Q1 | $67K | Buy |
774
+24
| +3% | +$2.15K | 0.01% | 375 |
|
|
2015
Q4 | $85K | Hold |
750
| – | – | 0.02% | 346 |
|
|
2015
Q3 | $76K | Hold |
750
| – | – | 0.02% | 360 |
|
|
2015
Q2 | $92K | Hold |
750
| – | – | 0.02% | 335 |
|
|
2015
Q1 | $86K | Hold |
750
| – | – | 0.02% | 342 |
|
|
2014
Q4 | $76K | Hold |
750
| – | – | 0.01% | 345 |
|
|
2014
Q3 | $68K | Hold |
750
| – | – | 0.01% | 343 |
|
|
2014
Q2 | $64K | Hold |
750
| – | – | 0.01% | 356 |
|
|
2014
Q1 | $59K | Buy |
+750
| New | +$62.5K | 0.01% | 361 |
|
Other funds holding IBB
CB
North Star Investment Management's IBB Position: Q1 2026 in Review
North Star Investment Management increased its iShares Biotechnology ETF (IBB) stake by 6.7% in Q1 2026, buying an estimated $14.4K and bringing the position to 1,347 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #482.
North Star Investment Management first reported a position in IBB in Q1 2014 and has held it in 48 quarters since. The position peaked at $416K in Q4 2021. 918 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- North Star Investment Management held 1,347 shares of iShares Biotechnology ETF worth $227K as of Q1 2026.
- North Star Investment Management bought 84 iShares Biotechnology ETF shares in Q1 2026, an estimated $14.4K.
- iShares Biotechnology ETF made up 0.01% of North Star Investment Management's portfolio in Q1 2026, its #482 holding.
- North Star Investment Management first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 48 quarters since.
- North Star Investment Management's iShares Biotechnology ETF position peaked at $416K in Q4 2021.
- 918 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.